At the news
? NEUTRALIMPACT 2/10 8-K filed Nov 3, 2026 at 20:30 ET
Bio-Techne filed an 8-K announcing a quarterly cash dividend of $0.08 per share for the quarter ended September 30, 2026, payable on November 23, 2026 to holders of record on November 13, 2026. The dividend is contingent on the pending acquisition by Merck KGaA not closing on or before the record date. This is a routine capital allocation event with no material financial impact.
- Quarterly dividend of $0.08 per share declared for the quarter ended September 30, 2026
- Payable November 23, 2026 to shareholders of record on November 13, 2026
- Dividend is contingent on the pending Merck KGaA acquisition not closing on or before November 13, 2026
- Future dividends to be considered quarterly by the Board
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access